Skin Deep

Enhanced Variable May Help Explain Racial Disparities in Type 2 Diabetes and Prediabetes

Celia C. Lo, Joanna Lara, Tyrone Cheng

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Abstract

Introduction: The study refined definitions of type 2 diabetes and prediabetes (Pre-/T2D) via its four-category outcome variable. Respondents were identified as Pre-/T2D on the basis of (a) doctor’s diagnosis only (i.e., managed Pre-/T2D); (b) biomarker only (i.e., undiagnosed Pre-/T2D); or (c) both diagnosis and biomarker (i.e., unmanaged Pre-/T2D). The reference was Pre-/T2D not indicated. We linked the outcome to social structural and social support factors, health care-related factors, mental disorder, and lifestyle variables, for each racial/ethnic group. Methods: We used the 2011–2012 and 2013–2014 National Health and Nutrition Examination Surveys to measure the four-category outcome and examine race/ethnicity’s role in explaining the outcome. Results: We found Pre-/T2D to be associated with age, BMI, physical activity, income, education, receiving health services, and other factors. A moderating role for race/ethnicity was also confirmed. Conclusion: The racial disparities observed in our three main categories generally resulted from high levels of undiagnosed Pre-/T2D and high levels of diagnosed but unmanaged Pre-T2D. Race/ethnicity’s moderating role generally indicated that, through the factors BMI, age, and receiving health services, minority status (with its attendant disadvantages) could facilitate undiagnosed Pre-/T2D as well as Pre-/T2D indicated concurrently by diagnosis and biomarker.

Original languageEnglish
Pages (from-to)837-850
Number of pages14
JournalDiabetes Therapy
Volume8
Issue number4
DOIs
StatePublished - 1 Aug 2017

Fingerprint

Prediabetic State
Type 2 Diabetes Mellitus
Biomarkers
Skin
Health Services
Nutrition Surveys
Age Factors
Ethnic Groups
Mental Disorders
Social Support
Life Style
Exercise
Delivery of Health Care
Education

Keywords

  • Biomarker
  • Multiple disadvantage model
  • Racial disparities
  • Type 2 diabetes and prediabetes (Pre-/T2D)
  • Undiagnosed Pre-/T2D
  • Unmanaged Pre-/T2D

Cite this

Lo, Celia C. ; Lara, Joanna ; Cheng, Tyrone. / Skin Deep : Enhanced Variable May Help Explain Racial Disparities in Type 2 Diabetes and Prediabetes. In: Diabetes Therapy. 2017 ; Vol. 8, No. 4. pp. 837-850.
@article{3df2f7344ae94603b93a91299cd9f44f,
title = "Skin Deep: Enhanced Variable May Help Explain Racial Disparities in Type 2 Diabetes and Prediabetes",
abstract = "Introduction: The study refined definitions of type 2 diabetes and prediabetes (Pre-/T2D) via its four-category outcome variable. Respondents were identified as Pre-/T2D on the basis of (a) doctor’s diagnosis only (i.e., managed Pre-/T2D); (b) biomarker only (i.e., undiagnosed Pre-/T2D); or (c) both diagnosis and biomarker (i.e., unmanaged Pre-/T2D). The reference was Pre-/T2D not indicated. We linked the outcome to social structural and social support factors, health care-related factors, mental disorder, and lifestyle variables, for each racial/ethnic group. Methods: We used the 2011–2012 and 2013–2014 National Health and Nutrition Examination Surveys to measure the four-category outcome and examine race/ethnicity’s role in explaining the outcome. Results: We found Pre-/T2D to be associated with age, BMI, physical activity, income, education, receiving health services, and other factors. A moderating role for race/ethnicity was also confirmed. Conclusion: The racial disparities observed in our three main categories generally resulted from high levels of undiagnosed Pre-/T2D and high levels of diagnosed but unmanaged Pre-T2D. Race/ethnicity’s moderating role generally indicated that, through the factors BMI, age, and receiving health services, minority status (with its attendant disadvantages) could facilitate undiagnosed Pre-/T2D as well as Pre-/T2D indicated concurrently by diagnosis and biomarker.",
keywords = "Biomarker, Multiple disadvantage model, Racial disparities, Type 2 diabetes and prediabetes (Pre-/T2D), Undiagnosed Pre-/T2D, Unmanaged Pre-/T2D",
author = "Lo, {Celia C.} and Joanna Lara and Tyrone Cheng",
year = "2017",
month = "8",
day = "1",
doi = "10.1007/s13300-017-0278-z",
language = "English",
volume = "8",
pages = "837--850",
journal = "Diabetes Therapy",
issn = "1869-6953",
publisher = "Springer Publishing Company",
number = "4",

}

Skin Deep : Enhanced Variable May Help Explain Racial Disparities in Type 2 Diabetes and Prediabetes. / Lo, Celia C.; Lara, Joanna; Cheng, Tyrone.

In: Diabetes Therapy, Vol. 8, No. 4, 01.08.2017, p. 837-850.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Skin Deep

T2 - Enhanced Variable May Help Explain Racial Disparities in Type 2 Diabetes and Prediabetes

AU - Lo, Celia C.

AU - Lara, Joanna

AU - Cheng, Tyrone

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Introduction: The study refined definitions of type 2 diabetes and prediabetes (Pre-/T2D) via its four-category outcome variable. Respondents were identified as Pre-/T2D on the basis of (a) doctor’s diagnosis only (i.e., managed Pre-/T2D); (b) biomarker only (i.e., undiagnosed Pre-/T2D); or (c) both diagnosis and biomarker (i.e., unmanaged Pre-/T2D). The reference was Pre-/T2D not indicated. We linked the outcome to social structural and social support factors, health care-related factors, mental disorder, and lifestyle variables, for each racial/ethnic group. Methods: We used the 2011–2012 and 2013–2014 National Health and Nutrition Examination Surveys to measure the four-category outcome and examine race/ethnicity’s role in explaining the outcome. Results: We found Pre-/T2D to be associated with age, BMI, physical activity, income, education, receiving health services, and other factors. A moderating role for race/ethnicity was also confirmed. Conclusion: The racial disparities observed in our three main categories generally resulted from high levels of undiagnosed Pre-/T2D and high levels of diagnosed but unmanaged Pre-T2D. Race/ethnicity’s moderating role generally indicated that, through the factors BMI, age, and receiving health services, minority status (with its attendant disadvantages) could facilitate undiagnosed Pre-/T2D as well as Pre-/T2D indicated concurrently by diagnosis and biomarker.

AB - Introduction: The study refined definitions of type 2 diabetes and prediabetes (Pre-/T2D) via its four-category outcome variable. Respondents were identified as Pre-/T2D on the basis of (a) doctor’s diagnosis only (i.e., managed Pre-/T2D); (b) biomarker only (i.e., undiagnosed Pre-/T2D); or (c) both diagnosis and biomarker (i.e., unmanaged Pre-/T2D). The reference was Pre-/T2D not indicated. We linked the outcome to social structural and social support factors, health care-related factors, mental disorder, and lifestyle variables, for each racial/ethnic group. Methods: We used the 2011–2012 and 2013–2014 National Health and Nutrition Examination Surveys to measure the four-category outcome and examine race/ethnicity’s role in explaining the outcome. Results: We found Pre-/T2D to be associated with age, BMI, physical activity, income, education, receiving health services, and other factors. A moderating role for race/ethnicity was also confirmed. Conclusion: The racial disparities observed in our three main categories generally resulted from high levels of undiagnosed Pre-/T2D and high levels of diagnosed but unmanaged Pre-T2D. Race/ethnicity’s moderating role generally indicated that, through the factors BMI, age, and receiving health services, minority status (with its attendant disadvantages) could facilitate undiagnosed Pre-/T2D as well as Pre-/T2D indicated concurrently by diagnosis and biomarker.

KW - Biomarker

KW - Multiple disadvantage model

KW - Racial disparities

KW - Type 2 diabetes and prediabetes (Pre-/T2D)

KW - Undiagnosed Pre-/T2D

KW - Unmanaged Pre-/T2D

UR - http://www.scopus.com/inward/record.url?scp=85027004414&partnerID=8YFLogxK

U2 - 10.1007/s13300-017-0278-z

DO - 10.1007/s13300-017-0278-z

M3 - Article

VL - 8

SP - 837

EP - 850

JO - Diabetes Therapy

JF - Diabetes Therapy

SN - 1869-6953

IS - 4

ER -